AIDS and cancer in the era of highly active antiretroviral therapy (HAART)

European Journal of Cancer

Volumn 37, Issue 10, 2001, Pages 1316-1319

  Rabkin, C S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS related malignancy; Epstein Barr virus; HAART; Human herpesvirus 8; Kaposi's sarcoma; Non Hodgkin's lymphoma

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; FOSCARNET; GANCICLOVIR; INTERLEUKIN 2; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ANTIBIOTIC THERAPY; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HERPES; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MORBIDITY; MORTALITY; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0034979083     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00104-6     Document Type: Article

References (30)

1. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
2. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
3. Cancer death rates associated with human immunodeficiency virus infection in the United States
4. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia
5. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991
6. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy
7. AIDS across Europe, 1994-98: The EuroSIDA study
8. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study
9. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study. Swiss HIV Cohort Study
10. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study
11. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998
12. Combination antiretroviral therapy and incidence of AIDS-related malignancies
13. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants
14. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study
15. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults
16. Natural history of HIV infection in the era of combination antiretroviral therapy
17. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms
18. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons
19. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy
20. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy
21. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection
22. Use of antiherpes drugs and the risk of Kaposi's sarcoma: Data from the Multicenter AIDS Cohort Study
23. AIDS-associated Kaposi's sarcoma
24. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
25. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system
26. The role of Epstein-Barr virus in lymphomas of HIV-carriers
27. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus
28. Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: Case-control and historical cohort studies
29. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2
30. Combination of chemotherapy and antiviral therapy for Epstein-Barr virus-associated non-Hodgkin's lymphoma of high grade malignancy in cases of HIV infection